dc.contributor.author | Ubah, Obinna | |
dc.contributor.author | Porter, Andrew J | |
dc.contributor.author | Barelle, Caroline J | |
dc.date.accessioned | 2020-02-04T15:20:01Z | |
dc.date.available | 2020-02-04T15:20:01Z | |
dc.date.issued | 2020-02-03 | |
dc.identifier.citation | Ubah , O , Porter , A J & Barelle , C J 2020 , ' In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA : An Encouraging Milestone to Further Clinical Drug Development ' , Journal of Immunology Research , vol. 2020 , 7283239 , pp. 7283239 . https://doi.org/10.1155/2020/7283239 | en |
dc.identifier.issn | 2314-7156 | |
dc.identifier.other | PURE: 155763580 | |
dc.identifier.other | PURE UUID: 71d480ac-0f2f-4c0f-bfdb-12e960b1d5da | |
dc.identifier.other | PubMed: 32090129 | |
dc.identifier.other | Scopus: 85079741293 | |
dc.identifier.other | WOS: 000515768700001 | |
dc.identifier.uri | https://hdl.handle.net/2164/13655 | |
dc.description | Funding Information: The authors wish to acknowledge the funding support for this work from Scottish Enterprise (SE) (VNAR_001 (2012)), the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/K010905/1), and Innovate UK (102865). | en |
dc.format.extent | 14 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Immunology Research | en |
dc.rights | Copyright © 2020 Obinna C. Ubah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | ANTI-ADALIMUMAB ANTIBODIES | en |
dc.subject | TNF THERAPY | en |
dc.subject | INTERFERENCE | en |
dc.subject | MECHANISMS | en |
dc.subject | INFLIXIMAB | en |
dc.subject | DISEASES | en |
dc.subject | R Medicine | en |
dc.subject | Immunology and Allergy | en |
dc.subject | Immunology | en |
dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
dc.subject | BB/K010905/1 | en |
dc.subject.lcc | R | en |
dc.title | In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA : An Encouraging Milestone to Further Clinical Drug Development | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1155/2020/7283239 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85079741293&partnerID=8YFLogxK | en |